New tuberculosis therapy offers potential shorter treatment.
D000995:Antitubercular Agents / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D004359:Drug Therapy, Combination; D024841:Fluoroquinolones / Q000627:therapeutic use*; D000077734:Gatifloxacin; D006801:Humans; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D024841:Fluoroquinolones; D000077734:Gatifloxacin